The Company hereby informs that The Board of Directors in its meeting held on April 30, 2026, has approved the appointment of Chief Financial Officer of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 17.6 pts more than Nifty Microcap 250 and 18.0 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited reported strong audited financial results for FY2025-26 with total income of Rs 29,568 lakhs and profit after tax of Rs 1,103.71 lakhs, a significant turnaround from a loss of Rs 224.64 lakhs in the previous year. The Board recommended a final dividend of Rs 7 per equity share (70% payout) for shareholder approval at the AGM. In key management changes, Mr. Amit Goriwale stepped down as Interim CFO and CRO effective May 31, 2026, and Mr. Chirag Kothari, a Chartered Accountant with over 20 years of experience (previously Finance Controller and Head of Internal Audit at Wadia Group), was appointed as the new CFO and CRO effective June 1, 2026. Statutory auditors Kalyaniwalla & Mistry LLP issued an unmodified audit opinion on the financial results.
The appointment of a permanent, experienced CFO following the interim period provides greater stability in financial leadership. The strong financial turnaround and dividend recommendation are positive signals for shareholders, though the CFO transition may temporarily create some reporting uncertainty.